Search for a report

EUROPE CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • EUROPE CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

EUROPE CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

The Europe cartilage degeneration market is evaluated to record a CAGR of 4.41% during the forecasting period of 2021 to 2028. Key factors such as the rising incidence of sports activities and trauma accidents, the increasing emphasis on regenerative medicine, and the growing numbers of product approvals are set to facilitate the market growth of the region.

EUROPE CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

Europe Cartilage Degeneration Market by Procedure (Joint Replacement, Chondroplasty, Cell-based Cartilage Resurfacing, Osteochondral Transplant, Meniscus Transplants, Other Procedures) Market by Application (Knee, Hips, Other Applications) Market by End-user (Ambulatory Surgical Centers, Hospitals & Specialty Clinics, Academic & Research Institutes) by Geography

Request free sample

The Europe cartilage degeneration market is evaluated to record a CAGR of 4.41% during the forecasting period of 2021 to 2028. Key factors such as the rising incidence of sports activities and trauma accidents, the increasing emphasis on regenerative medicine, and the growing numbers of product approvals are set to facilitate the market growth of the region.europe-cartilage-degeneration-market

To learn more about this report, request a free sample copy

The Europe cartilage degeneration market growth assessment includes the evaluation of Russia, Germany, the United Kingdom, Italy, Belgium, Poland, France, and the rest of Europe. The increasing geriatric population in the United Kingdom is a key driving factor fueling the country’s cartilage degeneration market growth. According to the Later Life in the United Kingdom 2019 report, the nation has approximately 12 million people aged 65 and above. In addition, the increasing incidence of musculoskeletal disorders in the United Kingdom is likely to augment the demand for cartilage repair procedures.

On the other hand, the presence of clinics and hospitals providing advanced treatment procedures for cartilage repair plays a crucial role in propelling the market growth in Germany. In this regard, Gelenk Klinik, a certified orthopedic hospital, applies 3rd generation chondrosphere technology and offers autologous cartilage transplants. Besides, the German hospital has performed over 700 autologous cartilage transplant procedures, as well. Therefore, these aspects are anticipated to reinforce the Europe cartilage degeneration market growth.

Smith & Nephew PLC, headquartered in London, the United Kingdom, is an international medical devices business operating in the orthopedics, as well as advanced wound management and endoscopy markets. The company caters to surgeons, physicians, nurses and nurse specialists, physicians and general practitioners, retail consumers, surgeons, healthcare systems, payers and administrators, and procurement groups and patients.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • SPORTS INJURIES DAMAGING CARTILAGE AND LIGAMENTS
        • DEGENERATION OF CARTILAGE DUE TO OBESITY
        • BONE AND JOINT-RELATED DISEASES IN THE GERIATRIC POPULATION
      • KEY RESTRAINTS
        • HIGH COST OF CARTILAGE REPAIR THERAPIES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON CARTILAGE DEGENERATION MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYERS POWER
        • SUPPLIERS POWER
        • COMPETITIVE RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    3. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    4. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
          • COUNTRY ANALYSIS
          • GERMANY
          • UNITED KINGDOM
          • FRANCE
          • ITALY
          • RUSSIA
          • POLAND
          • BELGIUM
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ANIKA THERAPEUTICS INC
        • ARTHREX INC
        • B BRAUN MELSUNGEN AG
        • BIOTISSUE SA
        • CARTIHEAL INC
        • CONMED CORPORATION
        • DEPUY SYNTHES COMPANIES
        • OSIRIS THERAPEUTICS INC
        • RTI SURGICAL INC
        • SMITH & NEPHEW PLC
        • STRYKER CORPORATION
        • VERICEL CORPORATION
        • ZIMMER BIOMET HOLDINGS

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – CARTILAGE DEGENERATION

    TABLE 2: EUROPE CARTILAGE DEGENERATION MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE CARTILAGE DEGENERATION MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE CARTILAGE DEGENERATION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE CARTILAGE DEGENERATION MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE CARTILAGE DEGENERATION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE CARTILAGE DEGENERATION MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE CARTILAGE DEGENERATION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE CARTILAGE DEGENERATION MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN THE EUROPE CARTILAGE DEGENERATION MARKET

    TABLE 11: LIST OF MERGERS & ACQUISITIONS

    TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE CARTILAGE DEGENERATION MARKET, BY PROCEDURE, IN 2020

    FIGURE 6: EUROPE CARTILAGE DEGENERATION MARKET, BY JOINT REPLACEMENT, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE CARTILAGE DEGENERATION MARKET, BY CHONDROPLASTY, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE CARTILAGE DEGENERATION MARKET, BY CELL-BASED CARTILAGE RESURFACING, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE CARTILAGE DEGENERATION MARKET, BY OSTEOCHONDRAL TRANSPLANT, 2021-2028 (IN $ MILLION)

    FIGURE 10: EUROPE CARTILAGE DEGENERATION MARKET, BY MENISCUS TRANSPLANTS, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE CARTILAGE DEGENERATION MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE CARTILAGE DEGENERATION MARKET, BY APPLICATION, IN 2020

    FIGURE 13: EUROPE CARTILAGE DEGENERATION MARKET, BY KNEE, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE CARTILAGE DEGENERATION MARKET, BY HIPS, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE CARTILAGE DEGENERATION MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE CARTILAGE DEGENERATION MARKET, BY END-USER, IN 2020

    FIGURE 17: EUROPE CARTILAGE DEGENERATION MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

    FIGURE 18: EUROPE CARTILAGE DEGENERATION MARKET, BY HOSPITALS & SPECIALTY CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE CARTILAGE DEGENERATION MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE CARTILAGE DEGENERATION MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 21: GERMANY CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 22: UNITED KINGDOM CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 23: FRANCE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: ITALY CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 25: RUSSIA CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: POLAND CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 27: BELGIUM CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 28: REST OF EUROPE CARTILAGE DEGENERATION MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • UNITED KINGDOM
          • FRANCE
          • ITALY
          • RUSSIA
          • POLAND
          • BELGIUM
          • REST OF EUROPE
    1. MARKET BY PROCEDURE
      • JOINT REPLACEMENT
      • CHONDROPLASTY
      • CELL-BASED CARTILAGE RESURFACING
      • OSTEOCHONDRAL TRANSPLANT
      • MENISCUS TRANSPLANTS
      • OTHER PROCEDURES
    2. MARKET BY APPLICATION
      • KNEE
      • HIPS
      • OTHER APPLICATIONS
    3. MARKET BY END-USER
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS & SPECIALTY CLINICS
      • ACADEMIC & RESEARCH INSTITUTES

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now